foundayo orforglipron UK

Foundayo (Orforglipron) Tablets

Price range: £83.00 through £140.00

Foundayo (Orforglipron)

Foundayo is a once-daily prescription tablet containing orforglipron, a small-molecule GLP-1 receptor agonist made by Eli Lilly.

It is licensed in the UK for weight management in adults with a BMI of 30 kg/m² or above, or a BMI of 27–30 kg/m² with at least one weight-related condition such as prediabetes, type 2 diabetes, high blood pressure, abnormal blood fats, obstructive sleep apnoea, or cardiovascular disease. It is used alongside a reduced-calorie diet and increased physical activity. Foundayo is separately licensed to improve blood sugar control in adults with insufficiently controlled type 2 diabetes.

Unlike peptide-based oral GLP-1 medicines, Foundayo can be taken at any time of day, with or without food, and does not require refrigeration.

 

 

Clear
Start Assessment

Description

Buy Foundayo UK – Orforglipron Weight Loss Tablets From £83

Looking to buy Foundayo in the UK? Slinic provides Foundayo (orforglipron) weight loss tablets online from £83, subject to medical assessment, eligibility and approval by a qualified prescriber.

Foundayo is a once-daily prescription GLP-1 weight loss tablet licensed in the UK for weight management in eligible adults. It provides an oral alternative for people who would prefer a daily weight loss tablet rather than a weekly weight loss injection.

At Slinic, you can order Foundayo online through our UK clinician-led weight management service. Complete your online medical assessment and our clinical team will review your suitability before treatment is prescribed and supplied from our UK-registered pharmacy.

Foundayo Price UK – From £83

Foundayo prices at Slinic start from £83, with transparent pricing and no subscription or monthly membership fees. The Foundayo cost covers the medicine itself, with no separate consultation charge at any point in treatment.

When you buy Foundayo through Slinic, you receive:

  • Foundayo from £83
  • No subscription fees
  • No hidden monthly membership charges
  • Online medical assessment
  • Review by a qualified prescriber
  • Video consultation for new patients where required
  • UK pharmacy dispensing
  • Ongoing clinical support
  • Nutrition and lifestyle advice
  • Treatment and dose reviews
  • Tracked UK delivery following clinical approval and stock availability

Our aim is to make it straightforward to buy Foundayo online in the UK while ensuring treatment remains clinically appropriate and professionally supervised.

Start your Foundayo assessment

What Is Foundayo (Orforglipron)?

Foundayo contains orforglipron, a small-molecule GLP-1 receptor agonist used for weight management.

It works by helping to reduce appetite and increase feelings of fullness, supporting reduced calorie intake when used alongside a reduced-calorie diet and increased physical activity.

Foundayo is an oral GLP-1 weight loss treatment taken once daily. The Foundayo tablet does not require refrigeration and can be taken without specific food or water timing requirements.

For detailed information about the treatment, read our complete Foundayo (orforglipron) UK guide.

Can I Buy Foundayo Online in the UK?

Yes. Eligible adults can buy Foundayo online through Slinic following an appropriate clinical assessment and prescription.

The process is straightforward:

  1. Select your Foundayo treatment and complete the online medical assessment.
  2. Provide the information required for our clinicians to assess your eligibility.
  3. Complete a video consultation where required.
  4. A qualified prescriber reviews your treatment.
  5. Following clinical approval and stock availability, your Foundayo is dispensed through our UK-registered pharmacy and sent using tracked delivery.

Placing an order does not guarantee that Foundayo will be prescribed. Medication is supplied only where our clinical team considers treatment safe and clinically appropriate.

You can also explore our weight loss treatments to learn more about prescription weight-management treatment available through Slinic, including Mounjaro (tirzepatide) and Wegovy (semaglutide).

Who Can Buy Foundayo Weight Loss Tablets?

Foundayo is a prescription-only medicine and is not suitable for everyone.

Eligibility is assessed individually and may take into account:

  • BMI
  • Current weight and height
  • Relevant weight-related health conditions
  • Medical history
  • Current medicines
  • Previous weight-loss treatment
  • Previous GLP-1 treatment
  • Contraindications and other clinical risk factors

Our prescribers review this information before deciding whether Foundayo is an appropriate treatment option.

Medicines in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).

Buy Foundayo Online From Slinic

When purchasing prescription weight-loss medication online, appropriate clinical assessment and pharmacy supply are important.

Slinic is a UK clinician-led weight management service, with prescribed treatment supplied through a UK-registered pharmacy.

Patients choosing Slinic benefit from:

  • Doctor and pharmacist-led care
  • UK-registered pharmacy dispensing
  • Experienced weight-management clinicians
  • Foundayo prices from £83
  • Transparent fixed pricing
  • No subscription fees
  • No hidden membership charges
  • Ongoing clinical reviews
  • Video consultations and personalised advice
  • Nutrition and lifestyle support
  • Treatment progression and dose reviews
  • Tracked UK delivery

Pharmacies and pharmacy professionals can be checked through the General Pharmaceutical Council (GPhC). Our service is clinically led by Shadeia Younis MPharmS, Superintendent Pharmacist and Independent Prescriber, GPhC registration 2052119.

Check if Foundayo is right for you

Foundayo Doses and Treatment Progression

Foundayo is available in different strengths, and treatment progression should be determined according to the approved dosing schedule and individual clinical circumstances.

Patients should not change their Foundayo dose without appropriate clinical guidance.

Read our Foundayo doses guide for detailed information about available strengths, starting treatment and dose progression.

Foundayo Side Effects

As with other medicines, Foundayo can cause side effects. Patients should understand the potential effects of treatment and know when they should seek clinical advice.

Read our Foundayo side effects guide for more information about commonly reported effects and important safety information.

Foundayo Compared With Other Oral Weight Loss Treatments

Patients considering Foundayo may want to understand how it compares with other oral GLP-1 treatment options.

Our Foundayo vs Wegovy tablets guide provides a detailed comparison to help patients understand the differences between the treatments. You can also read our oral Wegovy pill guide.

Switching From Mounjaro to Foundayo

Patients who have previously used injectable weight-loss treatment may be considering moving to an oral treatment.

Switching between prescription weight-loss medicines should always be clinically assessed rather than undertaken without appropriate medical advice.

Read our switching from Mounjaro to Foundayo guide for detailed information for patients considering this change, or our Foundayo for weight maintenance guide if you are looking to hold weight loss already achieved on injections.

Learn More About Foundayo UK

We have created a dedicated collection of Foundayo information to help patients understand treatment before deciding whether to proceed.

Read our complete Foundayo UK guide for a comprehensive overview.

You can also read:

Order Foundayo Online With Slinic

If you are ready to proceed, start your Foundayo assessment online today.

Complete the medical questionnaire and your information will be reviewed by a qualified prescriber. If Foundayo is clinically appropriate for you, treatment can be approved and supplied through our UK-registered pharmacy, subject to stock availability.

Buy Foundayo UK from £83 – no subscription fees, clinician-led care and ongoing weight-management support.

Start your Foundayo assessment

Prescription-only medicine. Treatment is subject to eligibility, clinical assessment, prescribing approval and stock availability.

▼ This medicine is subject to additional monitoring. Suspected side effects can be reported through the MHRA Yellow Card scheme.

How It Works

How It Works

Orforglipron is a non-peptide GLP-1 receptor agonist. It binds to and activates GLP-1 receptors, including those in areas of the brain involved in appetite regulation, which reduces food intake.

It also improves blood sugar control by increasing glucose-dependent insulin secretion, reducing fasting glucagon, and improving insulin sensitivity. It delays gastric emptying; this effect is largest after the first dose and lessens over time.

Because orforglipron is a small molecule rather than a peptide, it is stable in the digestive tract without an absorption enhancer, which is why there are no fasting, water or timing restrictions.

Directions

Directions

Please refer to the patient information leaflet before starting any new medicine.

Administration: Take one tablet by mouth once daily, at any time of day, with or without food. Swallow whole — do not break, crush or chew. Do not take more than one tablet per day.

Dose titration: Start at 0.8 mg once daily for 30 days, then increase to 2.5 mg once daily. The dose may then be increased in steps to 5.5 mg, 9 mg, 14.5 mg and 17.2 mg, remaining at each dose for at least 30 days before any increase, based on response and tolerability. The maximum dose is 17.2 mg once daily. Do not take more than one tablet to achieve a higher dose.

Missed dose: Take it as soon as you remember. Do not take more than one dose in a day, and do not double up.
Stopping: Do not stop taking Foundayo without speaking to your prescriber.

Storage

Storage

Store in the original package to protect from light — this medicine is light sensitive.

No refrigeration is required.

Do not use after the expiry date printed on the carton and blister.

Keep out of the sight and reach of children.
Do not dispose of medicines in wastewater or household waste — ask your pharmacist how to dispose of medicines you no longer need.

Ingredients

Ingredients

Active ingredient:
Orforglipron (as orforglipron calcium) — 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg or 17.2 mg per film-coated tablet.

Tablet core:
Microcrystalline cellulose
Crospovidone
Copovidone
Sodium carbonate (anhydrous)
Magnesium stearate
Film coating:
Poly(vinyl alcohol)
Titanium dioxide
Macrogol
Talc
Iron oxide red (E172) — in the 0.8 mg, 5.5 mg, 9 mg and 17.2 mg tablets
Iron oxide yellow (E172) — in the 0.8 mg, 2.5 mg, 9 mg and 14.5 mg tablets
Iron oxide black (E172) — in the 5.5 mg and 17.2 mg tablets
Contains less than 1 mmol sodium (23 mg) per tablet — essentially sodium-free.

Side Effects

Side Effects

Very common (may affect more than 1 in 10 people):Nausea
Constipation
Diarrhoea
Vomiting
Indigestion (dyspepsia)
Abdominal pain
Low blood sugar when used with insulin, with or without metformin and/or an SGLT2 inhibitor
Gastrointestinal effects are usually mild to moderate. Nausea, diarrhoea and vomiting are most common when starting treatment or after a dose increase, and reduce over time.

Common (may affect up to 1 in 10 people):
Low blood sugar when used with a sulfonylurea
Dizziness
Headache
Fast pulse
Low blood pressure
Bloating
Burping
Reflux or heartburn (GORD)
Wind
Gallstones
Hair loss
Fatigue
Raised pancreatic enzymes (lipase, amylase)

Uncommon (may affect up to 1 in 100 people):
Acute pancreatitis — severe, persistent stomach and back pain. Seek medical attention immediately.
Low blood sugar when used without insulin or a sulfonylurea
Altered sense of taste
Abnormal sensation on touch
Frequency not known — seek medical advice:
Sudden changes in vision or unusual visual symptoms
Bowel obstruction — severe stomach pain, swollen tummy, vomiting, or inability to pass wind or open bowels
Severe constipation
Serious allergic reaction (anaphylaxis) — breathing difficulty, swelling of the face or throat, wheezing, fast heartbeat, pale cold skin, dizziness or weakness. Get immediate medical help.
Increased chance of food or liquid entering the lungs during surgery or procedures
Kidney problems, sometimes requiring dialysis
Report any suspected side effect via the Yellow Card scheme at yellowcard.mhra.gov.uk, or contact your prescriber or pharmacist.

Warnings

Warnings

Allergies: Do not take Foundayo if you are allergic to orforglipron or any of the other ingredients.

Pancreatitis: Foundayo has not been studied in people with a history of pancreatitis and should be used with caution. Tell your prescriber if you have ever had it.

Low blood sugar: If you take a sulfonylurea or insulin, your risk of hypoglycaemia is increased. Your prescriber may reduce the dose of those medicines, and you should monitor your blood glucose as instructed.

Digestive conditions: Tell your prescriber if you have severe digestive problems, including severe gastroparesis (delayed stomach emptying).

Dehydration and kidneys: Nausea, vomiting and diarrhoea can lead to dehydration, which may affect kidney function. Drink enough fluids, particularly if you have existing kidney problems.

Blood pressure: Foundayo may lower blood pressure. Tell your prescriber if you take medicines for high blood pressure.

Gallbladder: Tell your prescriber if you develop upper abdominal pain, yellowing of the skin or eyes, pale stools or fever.

Eyes: Tell your prescriber if you have diabetic retinopathy or macular oedema.

Heart failure: Foundayo is not recommended if you have severe (NYHA class IV) heart failure.

Surgery and anaesthesia: Tell your surgical team and anaesthetist that you are taking Foundayo before any procedure involving general anaesthesia or sedation, as GLP-1 medicines delay stomach emptying. Do not stop treatment on your own — the decision is for your prescriber and anaesthetist.

Liver: Not recommended in severe liver impairment.

Children and adolescents: Not for use under 18 years.

Oral contraceptives: Foundayo may reduce the effectiveness of oral hormonal contraception. If you use the oral contraceptive pill, switch to a non-oral method or add a barrier method (such as condoms) for 30 days after starting Foundayo and for 30 days after every dose increase.

Pregnancy and breastfeeding: Do not use during pregnancy or while breastfeeding. Use effective contraception during treatment. If you are planning a pregnancy, Foundayo should be stopped at least 3 weeks beforehand.

Other medicines: Tell your prescriber about all medicines you take. Interactions include clarithromycin, ketoconazole, itraconazole, ritonavir and telaprevir (which raise orforglipron levels); carbamazepine, phenytoin, rifampicin, bosentan, efavirenz and St John’s wort (which lower it); and simvastatin, rosuvastatin and topotecan (whose levels orforglipron may raise). Dose limits apply with some of these — your prescriber will advise.

  • Foundayo is licensed for adults with a BMI of 30 kg/m² or above, or 27–30 kg/m² with at least one weight-related condition such as prediabetes, type 2 diabetes, high blood pressure, abnormal blood fats, obstructive sleep apnoea or cardiovascular disease — alongside a reduced-calorie diet and increased physical activity. If you’re not sure whether you qualify, start the consultation and our prescribers will tell you. Meeting the criteria does not guarantee a prescription; suitability is assessed individually.

  • Yes, on private prescription from a GPhC-registered pharmacy. Slinic is registered with the General Pharmaceutical Council (No. 1033729), NHS-contracted and LegitScript-certified. You complete an online consultation, a UK-registered prescriber reviews it, and your treatment is dispensed by our own pharmacy team in Brierfield — not passed to a third-party dispenser.

  • Foundayo (orforglipron) is £85 for the 0.8 mg starting dose at Slinic, plus £4.99 delivery.  Slinic prices are fixed for every strength — no subscription, no repeat prescription fees, no consultation charge and no price rises as you titrate up. What you see is what you pay, every month.

  • Foundayo is a once-daily prescription tablet containing orforglipron, a small-molecule GLP-1 receptor agonist made by Eli Lilly. It is licensed for weight management and, separately, for improving blood sugar control in type 2 diabetes. If you’d like to know whether it fits your situation, our pharmacist-led team can talk it through before you order.

  • Both are once-daily oral GLP-1 tablets. Foundayo contains orforglipron and can be taken any time with or without food. The Wegovy pill contains semaglutide and must be taken on an empty stomach with a small amount of plain water, with a wait before eating or taking other medicines. Foundayo also holds a separate type 2 diabetes licence. Their trials were not designed for head-to-head comparison — which is appropriate for you is a decision for your prescriber. Slinic supplies both, so our prescribers can recommend based on your circumstances rather than what happens to be in stock.

  • Yes, with a prescriber’s assessment. Doses are not interchangeable between different active ingredients, so your prescriber will decide the appropriate starting point based on your current treatment, how long you’ve been on it and how well you tolerate it. If you’re already established on an injectable and doing well, the assessment will take that into account. Slinic supplies Mounjaro, Wegovy and Foundayo, so a switch can be managed by the same clinical team without starting over somewhere new. Never take two GLP-1 medicines at the same time.

  • No. There is no fasting window, no water restriction and no waiting period before eating. Orforglipron is a small molecule rather than a peptide, so it does not need an absorption enhancer to survive digestion — which makes it simpler to fit around work, shifts and family routines.

  • Complete the online medical questionnaire covering your health history, current medicines and measurements — it takes a few minutes. A Slinic prescriber reviews it and either issues a prescription or contacts you directly to discuss alternatives. No appointment, no waiting list, no GP referral. Completing a consultation does not guarantee approval.

  • No. Store the tablets in their original packaging to protect them from light, as the medicine is light sensitive. Keep out of the sight and reach of children. No fridge means no cold-chain worries with delivery, travel or holidays.

  • One tablet once daily, at any time of day, with or without food. Swallow whole — do not break, crush or chew. Never take more than one tablet in a day. Every Slinic order comes with clear instructions, and our pharmacists are available if you have questions once you start.

  • Delivery is £4.99, fully tracked and in plain discreet packaging. Orders are dispensed in-house, so there’s no handover delay between prescriber and pharmacy.

  • Not currently. MHRA authorisation covers whether a medicine can be sold in the UK; NHS funding is a separate decision following a NICE appraisal, and there’s no confirmed date. Private prescription is the only route for now — Slinic offers it at fixed pricing from £85 with no subscription.

  • Yes. The MHRA authorised orforglipron under the brand name Foundayo on 10 August 2026, making the UK the first country in Europe to license it. It is prescription-only and carries a black triangle (▼), meaning it is subject to additional MHRA monitoring. Slinic supplies genuine, UK-licensed Eli Lilly stock through the regulated supply chain.

  • Six strengths: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg. Treatment starts at 0.8 mg for 30 days, then steps up with at least 30 days at each dose, so reaching 17.2 mg takes a minimum of five months. At Slinic your dose reviews are included — there’s no extra charge to move up a strength, and no new consultation fee each time.

  • Nausea, constipation, diarrhoea, vomiting, indigestion and abdominal pain are very common. These are usually mild to moderate, most likely when starting treatment or after a dose increase, and tend to settle over time. See the full side effects section above and the leaflet supplied with your medicine. If side effects are troubling you, contact the Slinic team — we can review your dose rather than leaving you to manage alone.

  • Slinic is pharmacist-led and SCOPE Obesity-accredited, with clinical support included in the price rather than sold as an add-on subscription.

  • If you’re new to GLP-1 treatment, yes — everyone starts at 0.8 mg of Foundayo (orforglipron) for the first 30 days. If you’re already on an injectable GLP-1, your Slinic prescriber will assess your treatment history and advise on the right starting dose for you.

  • If Foundayo isn’t right for you, our prescribers will explain why and talk you through the other treatments we offer, so you’re not left without a next step.

Related products

Wegovy (Semaglutide) Injection

Wegovy (Semaglutide) Injection

Starting from Price range: £83.00 through £350.00
Start Assessment This product has multiple variants. The options may be chosen on the product page
Wegovy pill tablets/injections

Wegovy (Semaglutide) Tablets

Starting from Price range: £92.00 through £164.00
Start Assessment This product has multiple variants. The options may be chosen on the product page
Mounjaro – Weight Loss Injection for Obesity and Metabolic Health

Mounjaro (Tirzepatide) Injection

Starting from Price range: £129.00 through £267.00
Start Assessment This product has multiple variants. The options may be chosen on the product page